Page last updated: 2024-08-23

paroxetine and amoxapine

paroxetine has been researched along with amoxapine in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (45.45)29.6817
2010's6 (54.55)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Ahman, M; Holmén, AG; Wan, H1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ1
Ekins, S; Williams, AJ; Xu, JJ1
Dalvie, D; Loi, CM; Smith, DA1
Bellman, K; Knegtel, RM; Settimo, L1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Katsu, H; Nakayama, K; Ochiai, Y; Okino, S; Wakutsu, N1
Kato, S; Nishida, S; Nisijima, K; Shioda, K1
Fujimura, Y; Suhara, T1
Fujiyama, Y; Kato, M; Kinoshita, T; Nishida, K; Sakai, S; Sugimoto, T; Suwa, A; Tajika, A; Takekita, Y; Wakeno, M1

Reviews

2 review(s) available for paroxetine and amoxapine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
[Biological pathophysiology of mood disorders special reference to the neurotransmitter receptors].
    Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica, 2004, Volume: 106, Issue:8

    Topics: Amoxapine; Animals; Antidepressive Agents, Second-Generation; Brain; Humans; Ligands; Membrane Glycoproteins; Membrane Transport Proteins; Mood Disorders; Nerve Tissue Proteins; Paroxetine; Receptor, Serotonin, 5-HT1A; Receptors, Dopamine D1; Receptors, Serotonin, 5-HT2; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Trazodone

2004

Other Studies

9 other study(ies) available for paroxetine and amoxapine

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs.
    Journal of medicinal chemistry, 2009, Mar-26, Volume: 52, Issue:6

    Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry

2009
Developing structure-activity relationships for the prediction of hepatotoxicity.
    Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes

2010
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010
Which metabolites circulate?
    Drug metabolism and disposition: the biological fate of chemicals, 2013, Volume: 41, Issue:5

    Topics: Humans; Metabolic Clearance Rate; Pharmaceutical Preparations

2013
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
    Pharmaceutical research, 2014, Volume: 31, Issue:4

    Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation

2014
[Case of prolonged recovery from serotonin syndrome caused by paroxetine].
    Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica, 2003, Volume: 105, Issue:12

    Topics: Amoxapine; Cytochrome P-450 CYP2D6; Depression; Diagnosis, Differential; Drug Interactions; Humans; Male; Middle Aged; Paroxetine; Polymorphism, Genetic; Serotonin Syndrome; Time Factors

2003
Possible serotonin syndrome arising from an interaction between caffeine and serotonergic antidepressants.
    Human psychopharmacology, 2004, Volume: 19, Issue:5

    Topics: Adult; Amoxapine; Caffeine; Central Nervous System Stimulants; Drug Interactions; Female; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Suicide, Attempted

2004
Syndrome of inappropriate secretion of anti-diuretic hormone in an elderly depressive patient receiving paroxetine: a case report.
    International journal of geriatric psychiatry, 2010, Volume: 25, Issue:4

    Topics: Amoxapine; Antidepressive Agents, Second-Generation; Depressive Disorder; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sodium; Treatment Outcome

2010